Published in Antimicrob Agents Chemother on December 01, 1979
Purification and properties of inducible penicillin beta-lactamase isolated from Pseudomonas maltophilia. Antimicrob Agents Chemother (1982) 7.11
Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia. Clin Microbiol Rev (1998) 5.33
Purification and properties of an inducible cephalosporinase from Pseudomonas maltophilia GN12873. Antimicrob Agents Chemother (1984) 3.07
A changing pattern of susceptibility of Xanthomonas maltophilia to antimicrobial agents: implications for therapy. Antimicrob Agents Chemother (1994) 2.10
Antimicrobial therapy for Stenotrophomonas maltophilia infections. Eur J Clin Microbiol Infect Dis (2007) 2.01
Associated mortality and clinical characteristics of nosocomial Pseudomonas maltophilia in a university hospital. J Clin Microbiol (1986) 1.84
SmeC, an outer membrane multidrug efflux protein of Stenotrophomonas maltophilia. Antimicrob Agents Chemother (2002) 1.60
In vitro susceptibility of Xanthomonas (Pseudomonas) maltophilia to newer antimicrobial agents. Antimicrob Agents Chemother (1990) 1.52
Stenotrophomonas maltophilia: emergence of multidrug-resistant strains during therapy and in an in vitro pharmacodynamic chamber model. Antimicrob Agents Chemother (1996) 1.28
Serological classification of Xanthomonas maltophilia (Pseudomonas maltophilia) based on heat-stable O antigens. J Clin Microbiol (1989) 1.28
Synergistic interactions of ciprofloxacin and extended-spectrum beta-lactams or aminoglycosides against multiply drug-resistant Pseudomonas maltophilia. Antimicrob Agents Chemother (1988) 1.20
Effect of temperature on antimicrobial susceptibilities of Pseudomonas maltophilia. J Clin Pathol (1985) 1.20
Stenotrophomonas maltophilia resistant to trimethoprim-sulfamethoxazole: an increasing problem. Ann Clin Microbiol Antimicrob (2006) 1.16
In vitro activities of antimicrobial combinations against Stenotrophomonas (Xanthomonas) maltophilia. Antimicrob Agents Chemother (1995) 1.12
Update on infections caused by Stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic options. Front Microbiol (2015) 1.06
Infective endocarditis due to Stenotrophomonas (Xanthomonas) maltophilia. Eur J Clin Microbiol Infect Dis (1998) 0.92
Cation concentration variability of four distinct Mueller-Hinton agar brands influences polymyxin B susceptibility results. J Clin Microbiol (2012) 0.91
Effect of calcium, magnesium, and zinc on ticarcillin and tobramycin alone and in combination against Pseudomonas aeruginosa. Antimicrob Agents Chemother (1982) 0.85
Prevalence of serotypes of Xanthomonas maltophilia from world-wide sources. Epidemiol Infect (1992) 0.79
Stenotrophomonas maltophilia virulence and specific variations in trace elements during acute lung infection: implications in cystic fibrosis. PLoS One (2014) 0.75
Pseudomonas and all that. Arch Dis Child (1999) 0.75
Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol (1966) 159.00
Antagonists of nucleic acid derivatives. VIII. Synergism in combinations of biochemically related antimetabolites. J Biol Chem (1954) 8.47
Antibiotic susceptibility testing of Pseudomonas aeruginosa: selection of a control strain and criteria for magnesium and calcium content in media. J Infect Dis (1974) 7.65
Effect of calcium and magnesium ions on the susceptibility of Pseudomonas species to tetracycline, gentamicin polymyxin B, and carbenicillin. Antimicrob Agents Chemother (1975) 3.32
Effect of cation content of agar on the activity of gentamicin, tobramycin, and amikacin against Pseudomonas aeruginosa. J Infect Dis (1978) 3.29
Nonfermentative gram-negative bacilli of nosocomial interest. Am J Med (1970) 3.08
Bacteremia with and without meningitis due to Yersinia enterocolitica, Edwardsiella tarda, Comamonas terrigena, and Pseudomonas maltophilia. Ann N Y Acad Sci (1970) 2.38
Pseudomonas maltophilia endocarditis after replacement of the mitral valve: a case study. J Infect Dis (1973) 1.84
In vitro antibiotic susceptibility of pseudomonads other than Pseudomonas aeruginosa recovered from cancer patients. Antimicrob Agents Chemother (1972) 1.82
Pseudomonas maltophilia infections in man. Am J Clin Pathol (1969) 1.76
Pseudomonas maltophilia pseudosepticemia. Am J Med (1978) 1.58
Distribution in clinical material and identification of Pseudomonas maltophilia. J Clin Pathol (1979) 1.54
Synergistic effect of combinations of sulfamethoxazole, trimethoprim, and colistin against Pseudomonas maltophilia and Pseudomonas cepacia. Antimicrob Agents Chemother (1974) 1.35
Polymyxin B and rifampin: new regimen for multiresistant Serratia marcescens infections. Antimicrob Agents Chemother (1977) 1.30
Effect of different media on in vitro studies of antibiotic combinations. Appl Microbiol (1968) 1.24
In vitro susceptibility of Pseudomanas cepacia and Pseudomonas maltophilia to trimethoprim and trimethoprim-sulfamethoxazole. Antimicrob Agents Chemother (1975) 1.21
Susceptibilities of Pseudomonas species to tetracycline, minocycline, gentamicin, and tobramycin. Am J Clin Pathol (1978) 0.97
Pseudomonas maltophilia causing heroin-associated infective endocarditis. Arch Intern Med (1978) 0.97
Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med (2001) 9.08
The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance. Am J Med (1996) 6.49
Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. Ann Intern Med (1991) 5.85
Methicillin-resistant Staphylococcus aureus: a consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management. Am J Med (1993) 4.72
Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia. Clin Infect Dis (2000) 4.24
Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med (2000) 4.21
Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory. J Clin Microbiol (2001) 4.19
Legionellosis. N Engl J Med (1997) 4.12
New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases. Medicine (Baltimore) (1990) 4.04
Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients. Am J Med (1989) 3.98
Is pneumonia really the old man's friend? Two-year prognosis after community-acquired pneumonia. Lancet (1993) 3.89
Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: prospective assessment with implications for enhancing compliance. AIDS Care (1996) 3.70
Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. American Thoracic Society. Medical Section of the American Lung Association. Am Rev Respir Dis (1993) 3.68
Ubiquitousness of Legionella pneumophila in the water supply of a hospital with endemic Legionnaires' disease. N Engl J Med (1982) 3.25
Serratia marcescens: historical perspective and clinical review. N Engl J Med (1979) 3.08
Methicillin-resistant staphylococcal colonization and infection in a long-term care facility. Ann Intern Med (1991) 3.04
Glycine-containing selective medium for isolation of Legionellaceae from environmental specimens. Appl Environ Microbiol (1981) 3.00
Isolation of Legionella pneumophila from hospital shower heads. Ann Intern Med (1981) 2.89
Hot water systems as sources of Legionella pneumophila in hospital and nonhospital plumbing fixtures. Appl Environ Microbiol (1982) 2.88
Enterococcal superinfection and colonization after therapy with moxalactam, a new broad-spectrum antibiotic. Ann Intern Med (1981) 2.80
Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia: a commentary. Int J Antimicrob Agents (1999) 2.64
Do in vitro susceptibility data predict the microbiologic response to amphotericin B? Results of a prospective study of patients with Candida fungemia. J Infect Dis (1998) 2.61
Opportunistic lung infection due to "Pittsburgh Pneumonia Agent". N Engl J Med (1979) 2.49
Staphylococcus aureus nasal carriage and infection in patients on hemodialysis. Efficacy of antibiotic prophylaxis. N Engl J Med (1986) 2.44
Growth-supporting activity for Legionella pneumophila in tap water cultures and implication of hartmannellid amoebae as growth factors. Appl Environ Microbiol (1988) 2.32
Disease due to the Legionellaceae (other than Legionella pneumophila). Historical, microbiological, clinical, and epidemiological review. Medicine (Baltimore) (1989) 2.31
Evaluation of housestaff physicians' preparation and interpretation of sputum Gram stains for community-acquired pneumonia. J Gen Intern Med (1991) 2.28
Roseomonas, a new genus associated with bacteremia and other human infections. J Clin Microbiol (1993) 2.28
Infections caused by Pseudomonas maltophilia with emphasis on bacteremia: case reports and a review of the literature. Rev Infect Dis (1983) 2.27
Multiplication of Legionella pneumophila in unsterilized tap water. Appl Environ Microbiol (1982) 2.26
Detection of Salmonella typhi D, Vi, and d antigens, by slide coagglutination, in urine from patients with typhoid fever. J Clin Microbiol (1980) 2.15
Diagnosis of Legionnaires' disease. An update of laboratory methods with new emphasis on isolation by culture. JAMA (1983) 2.14
Therapeutic approaches in patients with candidemia. Evaluation in a multicenter, prospective, observational study. Arch Intern Med (1996) 2.09
Enhanced chlorine resistance of tap water-adapted Legionella pneumophila as compared with agar medium-passaged strains. Appl Environ Microbiol (1985) 2.04
Mode of transmission of Legionella pneumophila. A critical review. Arch Intern Med (1986) 2.04
Molecular cloning and pro-apoptotic activity of ICErelII and ICErelIII, members of the ICE/CED-3 family of cysteine proteases. J Biol Chem (1995) 2.02
Association of serotypes of Streptococcus pneumoniae with disease severity and outcome in adults: an international study. Clin Infect Dis (2007) 1.87
Osteomyelitis due to Veillonella parvula: case report and review. Clin Infect Dis (1992) 1.86
Antimicrobial resistance and clinical outcome of Bacteroides bacteremia: findings of a multicenter prospective observational trial. Clin Infect Dis (2000) 1.83
Ecology of Legionella pneumophila within water distribution systems. Appl Environ Microbiol (1985) 1.83
Significance of isolation of Aspergillus from the respiratory tract in diagnosis of invasive pulmonary aspergillosis. Results from a three-year prospective study. Am J Med (1986) 1.81
Comparison of molecular methods for subtyping patients and epidemiologically linked environmental isolates of Legionella pneumophila. J Infect Dis (1988) 1.80
Epidemiologic perspectives on Enterobacter for the infection control professional. Am J Infect Control (1994) 1.78
In vitro evaluation of combination of fluconazole and flucytosine against Cryptococcus neoformans var. neoformans. Antimicrob Agents Chemother (1995) 1.77
Effect of temperature, pH, and oxygen level on the multiplication of naturally occurring Legionella pneumophila in potable water. Appl Environ Microbiol (1985) 1.74
A pink-pigmented, oxidative, nonmotile bacterium as a cause of opportunistic infections. Arch Intern Med (1989) 1.73
Multiplication of Legionella spp. in tap water containing Hartmannella vermiformis. Appl Environ Microbiol (1991) 1.69
Susceptibility of Legionella pneumophila to chlorine in tap water. Appl Environ Microbiol (1983) 1.67
Comparative susceptibilities of Pseudomonas aeruginosa to 1-oxacephalosporin (LY 127935) and eight other antipseudomonal antimicrobial agents (old and new). Antimicrob Agents Chemother (1980) 1.62
Enterobacteriaceae and Pseudomonas aeruginosa recovered from vegetable salads. Appl Environ Microbiol (1976) 1.60
Trimethoprim-sulfamethoxazole for the prevention of spontaneous bacterial peritonitis in cirrhosis: a randomized trial. Ann Intern Med (1995) 1.59
High-dose acyclovir compared with short-course preemptive ganciclovir therapy to prevent cytomegalovirus disease in liver transplant recipients. A randomized trial. Ann Intern Med (1994) 1.59
Antimicrobial selection by a computer. A blinded evaluation by infectious diseases experts. JAMA (1979) 1.56
New medium for selection and presumptive identification of the Bacteroides fragilis group. J Clin Microbiol (1978) 1.55
Manual of culture methodology for Legionella. Semin Respir Infect (1987) 1.54
Extended-spectrum beta-lactamases: a call for improved detection and control. Clin Infect Dis (1999) 1.53
Infections caused by Pseudomonas maltophilia. Expanding clinical spectrum. Arch Intern Med (1987) 1.53
Efficacy of oral ciprofloxacin plus rifampin for treatment of malignant external otitis. Arch Otolaryngol Head Neck Surg (1989) 1.50
Bacteriocin (klebocin) sensitivity typing of klebsiella. J Clin Microbiol (1976) 1.48
Satellite growth of Legionella pneumophila with an environmental isolate of Flavobacterium breve. Appl Environ Microbiol (1983) 1.47
Beta-Lactam antibiotic-induced leukopenia in severe hepatic dysfunction: risk factors and implications for dosing in patients with liver disease. Am J Med (1993) 1.46
Erythromycin ototoxicity: prospective assessment with serum concentrations and audiograms in a study of patients with pneumonia. Am J Med (1992) 1.46
Listeria monocytogenes peritonitis in cirrhotic patients. Value of ascitic fluid gram stain and a review of literature. Dig Dis Sci (1994) 1.43
Potable water as a cause of sporadic cases of community-acquired legionnaires' disease. N Engl J Med (1992) 1.43
Role of aerobic gram-negative rods, anaerobes, and fungi in wound infection after head and neck surgery: implications for antibiotic prophylaxis. Head Neck (1989) 1.41
Protecting tomorrow's health care professionals against hepatitis B virus today. Arch Intern Med (1991) 1.40
Analysis of trends in antimicrobial resistance patterns among clinical isolates of Bacteroides fragilis group species from 1990 to 1994. Clin Infect Dis (1996) 1.38
Unusual bacterium, group Ve-2, causing peritonitis in a patient on continuous ambulatory peritoneal dialysis. J Clin Microbiol (1985) 1.36
Clinical demonstration of isolation of Nocardia asteroides on buffered charcoal-yeast extract media. J Clin Microbiol (1992) 1.36
Isolation of Pittsburgh pneumonia agent from nebulizers used in respiratory therapy. Ann Intern Med (1980) 1.36
Legionnaires' disease: new clinical perspective from a prospective pneumonia study. Am J Med (1982) 1.34
Infections caused by Legionella micdadei and Legionella pneumophila among renal transplant recipients. J Infect Dis (1984) 1.33
Nasal carriage of and infection with Staphylococcus aureus in HIV-infected patients. Ann Intern Med (1999) 1.32
Intraocular candidiasis in patients with candidemia. Clinical implications derived from a prospective multicenter study. Ophthalmology (1994) 1.32
In vitro activities of two novel oxazolidinones (U100592 and U100766), a new fluoroquinolone (trovafloxacin), and dalfopristin-quinupristin against Staphylococcus aureus and Staphylococcus epidermidis. Antimicrob Agents Chemother (1996) 1.29
MYCIN II: design and implementation of a therapy reference with complex content-based indexing. Proc AMIA Symp (1998) 1.28
Invasive gastrointestinal zygomycosis in a liver transplant recipient: case report and review of zygomycosis in solid-organ transplant recipients. Clin Infect Dis (1995) 1.28
Unusual infections caused by Pasteurella multocida. JAMA (1977) 1.26
Efficacy of two third-generation cephalosporins in prophylaxis for head and neck surgery. Arch Otolaryngol (1984) 1.25
Legionnaires' disease acquired within the homes of two patients. Link to the home water supply. JAMA (1987) 1.25
Invasive aspergillosis in liver transplant recipients in the 1990s. Transplantation (1997) 1.23
Potable water supply as the hospital reservoir for Pittsburgh pneumonia agent. Lancet (1982) 1.22
Comparative assessment of chlorine, heat, ozone, and UV light for killing Legionella pneumophila within a model plumbing system. Appl Environ Microbiol (1987) 1.22
Human acetyltransferase polymorphisms. Mutat Res (1997) 1.21
New antimicrobial agents as therapy for resistant gram-positive cocci. Eur J Clin Microbiol Infect Dis (2008) 1.21
Malignant external otitis: insights into pathogenesis, clinical manifestations, diagnosis, and therapy. Am J Med (1988) 1.21
Growth of 28 Legionella species on selective culture media: a comparative study. J Clin Microbiol (1993) 1.19
Influence of a metazoan infection in the mouse on enteric colonization and immune response to Escherichia coli. J Infect Dis (1974) 1.18
Effect of non-Legionellaceae bacteria on the multiplication of Legionella pneumophila in potable water. Appl Environ Microbiol (1985) 1.18
Pneumonia due to the Pittsburgh pneumonia agent: new clinical perspective with a review of the literature. Medicine (Baltimore) (1983) 1.17
Central nervous system lesions in adult liver transplant recipients: clinical review with implications for management. Medicine (Baltimore) (1994) 1.17
Synergy assessed by checkerboard. A critical analysis. Diagn Microbiol Infect Dis (1993) 1.16
Measurement of serum and tissue concentration of moxalactam using high pressure liquid chromatography. Ther Drug Monit (1981) 1.16
Potential in-hospital modes of transmission of Legionella pneumophila. Demonstration experiments for dissemination by showers, humidifiers, and rinsing of ventilation bag apparatus. Am J Med (1986) 1.15
Synergistic interaction in vitro with use of three antibiotics simultaneously against Pseudomonas maltophilia. J Infect Dis (1980) 1.14
Cefamandole-susceptible strains of Legionella pneumophila serogroup 1: implications for diagnosis and utility as an epidemiological marker. J Clin Microbiol (1992) 1.14
Pneumonia and multiple lung abscesses caused by dual infection with Legionella micdadei and Legionella pneumophila. Am Rev Respir Dis (1983) 1.14